We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Dr. Joan Genescà and Dr. Jose Luís Calleja
The aim of this session was to highlight the needs and perspectives from the point of view of different areas involved in clinical trials: research, regulatory bodies and the pharmaceutical industry.
Vall d'Hebron hosted last April 28th the first edition of the workshop on clinical trials in patients with non-alcoholic steatohepatitis (NASH) with compensated cirrhosis, organized by Dr. Joan Genescà, head of the Hepatology Department and clinical director at the Digestive Diseases area at Vall d'Hebron University Hospital, head of the Liver Diseases research group at Vall d'Hebron Research Institute (VHIR) and head of the Advanced Chronic Liver Disease research group at CIBERehd (ISCIII), and Juan Manuel Pericàs, member of the Liver Diseases research group and of the aforementioned CIBERehd group.
The aim of this session was to highlight the needs and perspectives of the different stakeholders involved in a clinical trial: research, regulatory bodies and the pharmaceutical industry. During the day, the regulatory environment and restrictions imposed by regulatory agencies, patient profiling and screening, and possible alternatives for clinical trial design were discussed.
An exceptional aspect of this workshop was to have the participation of national and international experts from the different fields involved in this type of trials from the academic world and the pharmaceutical industry, which resulted in very productive and comprehensive discussions. "The value of this workshop is to bring together experts from different specialties (portal hypertension and cirrhosis, NASH, pharmaceutical industry and regulators) in the same space, which are essential elements when designing a clinical trial", explained Dr. Joan Genescà during the opening of the event.
This first event served to initiate a debate on the challenges faced by researchers in conducting these trials, which we hope can potentially contribute to new discussions and initiatives to advance the field.
Hepatology, General Hospital
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.